Global Epigenetics Market Report and Forecast 2024-2032

Global Epigenetics Market Outlook

The global epigenetics market stood at a value of around USD 1,285.68 million in 2023. The market is further expected to grow at a CAGR of 13.8% in the forecast period of 2024-2032 to attain a value of USD 4,100.62 million by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Kits Segment to Possess a Substantial Share of the Global Epigenetics Industry

Based on product, the kits segment holds a significant share in the global epigenetics industry. This growth can be attributed to the important role of kits in the entire epigenetic analysis process. Furthermore, this number is further expected to rise in the forecast period due to the increasing chronic illnesses and the growing geriatric population rates, which is very susceptible to acquiring various diseases, including cardiovascular diseases or cancer. Meanwhile, the oncology segment is estimated to observe a healthy growth in terms of application due to the high usage of epigenetic research in the oncology field.

North America to Account for a Significant Market Share of the Global Epigenetics Industry

North America is predicted to occupy a considerable share of the global epigenetics industry. This surge can be attributed to the increased utilisation of epigenetic research in the region and the increased investments in the development of the healthcare sector. Another factor influencing the market growth is the rising geriatric population in the region, who are susceptible to chronic diseases such as Parkinson’s disease and cancer.

Epigenetics: Market Segmentation

Epigenetics is an emerging scientific area of study that analyses how environmental influences impact the expression of genes. Based on different environmental experiences, genes are activated and deactivated by cells without any change in the underlying DNA structure of the organism and predict which proteins are transcribed. These external environmental stimuli can affect the genes, which could influence diseases. In addition, research has indicated that many human diseases occur due to the interaction between genetic variants and environmental exposure, such as autism, Parkinson’s disease, and breast cancer, among others.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By product, the market is divided into:

• Kits
• Reagents
• Enzymes
• Instruments

Kits are further divided by type into ChIP sequencing kits, bisulfite conversion kits, whole genome amplification kits, 5-hmC & 5-mC analysis kits, and RNA sequencing kits, among others. At the same time, reagents are further segmented by type into antibodies, magnetic beads, histones, buffers, primers, and others. Meanwhile, enzymes are categorised by type into DNA polymerases, DNA ligases, methyltransferases, acetylases, and reverse transcriptase, among others. And instruments are segregated by type into next-generation sequencers, qPCRs, mass spectrometers, sonicators, and others.

On the basis of application, the industry can be categorised into:

• Oncology 
• Non-Oncology

Oncology is further divided by type into solid tumours and liquid tumours, whereas non-oncology is segmented by type into metabolic diseases, infectious diseases, inflammatory diseases, cardiovascular diseases, and others.

Based on end use, the market can be segmented into:

• Academics and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organisations

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Prevalence of Cardiovascular Diseases to Augment the Growth of the Global Epigenetics Industry

According to WHO reports, cardiovascular diseases are the leading cause of death globally, claiming more than 17.9 million lives every year. Cardiovascular diseases are illnesses of heart and blood vessels that are adversely affected by high-risk behaviours such as unhealthy diet, physical inactivity, and substance abuse. In this regard, epigenetic research has found epigenetic biomarkers, a promising tool for the diagnosis and prognosis of many cardiovascular diseases. Some of their promising features include easy accessibility and feasibility in their detection methods, making them applicable for use in clinical interventions. This is significantly contributing to the growth of the market.

In a 2017 research by the American Diabetes Association, the researchers concluded that diabetes is a complication developed from the interaction of DNA structure variation and the environmental stimuli that causes changes in the cellular phenotype.

Key Industry Players in the Global Epigenetics Market

The report gives a detailed analysis of the following key players in the global epigenetics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Abcam Plc
• Active Motif, Inc.
• Agilent Technologies, Inc.
• Diagenode S.A.
• QIAGEN GmbH
• Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

Key Highlights of the Report